Join our Cancer Immunology Team
We are currently expanding our cancer immunology team in our three research locations (Vienna, Austria; Biberach, Germany; Ridgefield CT, USA) and especially in the US site where our Cancer Immunology research department is based and growing rapidly. With a record of innovation excellence that includes two marketed medicines for the treatment of non-small cell lung cancer, we are poised for the next wave of innovation with clinical phase projects now ongoing, involving checkpoint inhibitors, oncolytic viruses, cancer vaccines and T-cell engagers.

Join us as we strive to develop innovative medicines that change the way we treat cancer and have a positive impact on the lives of patients and their families.
